Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Good practices for the study of hemoglobin].

J Bardakdjian-Michau1, J-L Dhondt, R Ducrocq

  • 1Hôpital Henri Mondor, Créteil. josiane.michau@hmn.ap-hop-paris.fr

Annales De Biologie Clinique
|August 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neoadjuvant ipilimumab and nivolumab for resectable stage II mucosal melanoma.

Annales de dermatologie et de venereologie·2025
Same author

Deciphering Pain Experience in Adult Patients With Sickle Cell Disease: A Network Analysis of Pain-Related Factors in a Single French Sickle Cell Centre.

European journal of pain (London, England)·2025
Same author

Glucose-6-phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation.

Cytometry. Part B, Clinical cytometry·2024
Same author

La Revue de medecine interne·2023
Same author

La Revue de medecine interne·2023
Same author

Evaluation of a prophylactic transfusion program on obstetric outcomes in pregnant women with sickle cell disease: A single centre retrospective cohort study.

European journal of obstetrics, gynecology, and reproductive biology·2023

Hemoglobinopathies, including sickle cell disease (SCD), are a major health issue in France. Biologists play a key role in genetic diagnoses, with established neonatal screening programs for at-risk newborns.

Area of Science:

  • Medical Genetics
  • Hematology
  • Public Health

Context:

  • Hemoglobinopathies represent a significant national health concern in France.
  • Sickle cell disease (SCD) is the most common abnormality, with over 200 new cases annually at birth.
  • Diverse ethnic groups present various globin gene variations.

Purpose:

  • To outline clinical and technical recommendations for characterizing hemoglobin genetic variations.
  • To support the national neonatal sickle cell screening program established in 1995.
  • To emphasize the crucial role of biologists in genetic diagnoses of hemoglobinopathies.

Summary:

  • A national neonatal sickle cell screening program, supported by AFDPHE, has been in place since 1995 for at-risk newborns.
  • The program addresses the high incidence of sickle cell disease (SCD) and other globin gene variations.

Related Experiment Videos

  • Recommendations are provided for laboratory techniques essential for accurate genetic characterization.

    • Impact:

    • Enhances the diagnostic capabilities for hemoglobinopathies in France.
    • Improves early detection and management of sickle cell disease and related disorders.
    • Provides a framework for standardized laboratory practices in genetic hemoglobin analysis.